نتایج جستجو برای: UPDRS

تعداد نتایج: 1068  

2013
Gian Pal Christopher G. Goetz

OBJECTIVE Bradykinesia is one of the clinical hallmarks of Parkinson's disease (PD) and atypical Parkinsonian syndromes. Clinical ratings scales and technology-based assessments have been developed to measure bradykinesia. We review the different tools that exist for measurement of bradykinesia and analyze their reliability and applicability to PD and atypical Parkinsonian syndromes. METHODS ...

Journal: :Journal of rehabilitation research and development 2012
Frederick M Ivey Leslie I Katzel John D Sorkin Richard F Macko Lisa M Shulman

The Unified Parkinson's Disease Rating Scale (UPDRS) is a widely applied index of disease severity. Our objective was to assess the utility of UPDRS for predicting peak aerobic capacity (VO2 peak) and ambulatory function. Participants (n = 70) underwent evaluation for UPDRS (Total and Motor ratings), VO2 peak, 6-minute walk distance (6MW), and 30-foot self-selected walking speed (SSWS). Using r...

Journal: :Archives of neurology 2010
Lisa M Shulman Ann L Gruber-Baldini Karen E Anderson Paul S Fishman Stephen G Reich William J Weiner

OBJECTIVE To determine the estimates of minimal, moderate, and large clinically important differences (CIDs) for the Unified Parkinson's Disease Rating Scale (UPDRS). DESIGN Cross-sectional analysis of the CIDs for UPDRS total and motor scores was performed on patients with Parkinson disease (PD) using distribution- and anchor-based approaches based on the following 3 external standards: disa...

Journal: :IEEE Transactions on Neural Systems and Rehabilitation Engineering 2001

2017
Matej Skorvanek Zuzana Kosutzka Peter Valkovic Radka Ghorbani Saeedian Zuzana Gdovinova Jing Huang Barbara C. Tilley Glenn T. Stebbins Christopher G. Goetz

Recommendations for revision of the original version of Unified Parkinson’s Disease Rating Scale (UPDRS) were published based on its critique. Subsequently, a Movement Disorders Society (MDS)sponsored revision designated as the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) was presented. After its successful clinimetric testing, a program for translation and val...

2012
Marisa De Rose Giusy Guzzi Domenico Bosco Mary Romano Serena Marianna Lavano Massimiliano Plastino Giorgio Volpentesta Rosa Marotta Angelo Lavano

Motor Cortex Stimulation (MCS) is less efficacious than Deep Brain Stimulation (DBS) in Parkinson's disease. However, it might be proposed to patients excluded from DBS or unresponsive to DBS. Ten patients with advanced PD underwent unilateral MCS contralaterally to the worst clinical side. A plate electrode was positioned over the motor cortex in the epidural space through single burr hole aft...

Journal: :Movement disorders : official journal of the Movement Disorder Society 2008
Christopher G Goetz Barbara C Tilley Stephanie R Shaftman Glenn T Stebbins Stanley Fahn Pablo Martinez-Martin Werner Poewe Cristina Sampaio Matthew B Stern Richard Dodel Bruno Dubois Robert Holloway Joseph Jankovic Jaime Kulisevsky Anthony E Lang Andrew Lees Sue Leurgans Peter A LeWitt David Nyenhuis C Warren Olanow Olivier Rascol Anette Schrag Jeanne A Teresi Jacobus J van Hilten Nancy LaPelle

We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examina...

Objective(s): To evaluate the role of Tc-99m TRODAT-1 Single Photon Emission Computed Tomography (SPECT) in Parkinson’s Disease (PD) by assessing the correlation of clinical disease severity, disease duration and age at onset of disease with specific uptake ratio of Tc-99m TRODAT-1 in striatum.Methods: The study included 63 patients in age range of 40-72 years with clinical diagnosis of PD and ...

2014
Kristian Thorlund Ping Wu Eric Druyts Shawn Eapen Edward J Mills

OBJECTIVE To compare the efficacy of the three nonergot dopamine-receptor agonists (DAs) pramipexole, ropinirole, and rotigotine for the treatment of early and advanced Parkinson's disease (PD). MATERIALS AND METHODS Bayesian network meta-analyses were performed separately for early and advanced PD, and at time points 11-16 and 24-28 weeks. Outcomes for early PD included improvement on the Un...

Journal: :Physiology & Behavior 2013
Weidong Pan Shin Kwak Fuzhong Li Chunlan Wu Yiyun Chen Yoshiharu Yamamoto Dingfang Cai

Although the Unified Parkinson's Disease Rating Scale (UPDRS) is the "gold-standard" tool in assessing the severity of symptoms in patients with Parkinson's disease (PD), not all activity-related disease symptoms can be accurately captured by the well-established clinical rating scale. Using an alternative approach, this study examined the level of physical activity measured by actigraphy over ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید